TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off June 1, 2001